Pines Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$291K Sell
3,373
-146
-4% -$12.9K 0.08% 182
2026
Q2
$275K Sell
3,519
-1,654
-32% -$133K 0.08% 190
2026
Q1
$448K Buy
5,173
+355
+7% +$34K 0.15% 141
2025
Q4
$463K Buy
4,818
+227
+5% +$22K 0.15% 138
2025
Q3
$437K Sell
4,591
-2,692
-37% -$247K 0.15% 140
2025
Q2
$644K Buy
7,283
+920
+14% +$78K 0.23% 108
2025
Q1
$521K Buy
6,363
+2,515
+65% +$225K 0.24% 102
2024
Q4
$310K Buy
+3,848
New +$333K 0.14% 156

Other funds holding MDT

Pines Wealth Management's MDT Position: Q3 2026 in Review

Pines Wealth Management reduced its Medtronic (MDT) stake by 4.1% in Q3 2026, selling an estimated $12.9K and leaving 3,373 shares worth $291K. The position accounts for 0.08% of the portfolio, ranked #182.

Pines Wealth Management first reported a position in MDT in Q4 2024 and has held it in 8 quarters since. The position peaked at $644K in Q2 2025. 917 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Pines Wealth Management held 3,373 shares of Medtronic worth $291K as of Q3 2026.
  • Pines Wealth Management sold 146 Medtronic shares in Q3 2026, an estimated $12.9K.
  • Medtronic made up 0.08% of Pines Wealth Management's portfolio in Q3 2026, its #182 holding.
  • Pines Wealth Management first reported a position in Medtronic in Q4 2024 and has held it in 8 quarters since.
  • Pines Wealth Management's Medtronic position peaked at $644K in Q2 2025.
  • 917 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Pines Wealth Management's 13F filing for Q3 2026, filed 21 Oct 2026.